Immunohistochemistry Validation: Past, Present and Future26. Feb Online (US)
SAVE the DATE! Leica Biosystems invites you to attend "Immunohistochemistry Validation: Past, Present and Future" presented by Philip Ferguson, M.D, Doctor's Anatomic Pathology Services, Jonesboro, AR
Philip Ferguson, M.D. is a practicing pathologist in private practice located in Arkansas. He has a diverse training background that includes an undergraduate degree in mechanical engineering, post-graduate training in internal medicine, and board certifications in anatomic pathology, clinical pathology, and hematopathology.
His professional interests center on educational resource development for pathologists and trainees, and use of immunohistochemistry and molecular diagnostics in surgical pathology. Dr. Ferguson launched one of the first widespread internet educational tools for pathology residents to prepare for their board examination, PathMD (www.PathMD.com), which currently has over 3000 subscribers. Dr. Ferguson also serves as a state commissioner for the College of American Pathologists' Accreditation and Laboratory Improvement Program and is an adjunct clinical assistant professor at the University of Arkansas Medical Sciences.
Validation procedures are part of the regulatory process in a laboratory setting. Understanding the basic principles and reasons for validation is important for laboratory compliance of regulations and eventually for patient diagnosis and treatments of diseases. A discussion of current trends and changes with the latest CAP checklist will be reviewed and future direction of where IHC validation may end up will be discussed.
1. Understanding of the basic principles and reasons for the validation process.
2. Describe historical perspective of past IHC validation requirements.
3. Discuss current trends and changes in validation requirements (CAP latest checklist).
4. Examine the future direction of where the IHC validation process may end up.
Webinar On Demand hosted by Jennifer Burch